InsidersTradesSigma
Track the EPI stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Health Care sector, EPI has published 2 public disclosures. Market capitalisation: €68k. The latest transaction was filed on 17 May 2026 (Purchase). Among the most active insiders: Donal O’Dwyer. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€9,277
2 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate EPI Strong Buy (bullish), based on 2 analysts. Average price target: A$2.20.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 May 2026
Declarations2 total
21,500 shares@ A$0.46100.0% of flowShareASXASX:2924-03090954-3A693473
11,350 shares@ A$0.45100.0% of flowShareASXASX:2924-03090952-3A693472
2 of 2 declarations
关于 EPI
EPI 是一家在医疗保健和制药领域运营的公司。它在 XASX 市场上市。